mocysteinemia has been reported in human reproduction as a risk factor for early pregnancy loss, preeclampsia, and congenital birth defects like spina bifida. Female infertility was also observed in cystathionine beta synthase-deficient mice (Cbs-KO) as an animal model for severe hyperhomocysteinemia. The aim for the present research was to elucidate the time-point of pregnancy loss and to pinpoint gene and cellular changes involved in the underlying pathological mechanism. By mating 90-dayold wild-type and Cbs-KO female mice with their homologous male partners, we found that pregnancy loss in Cbs-KO occurred between the 8th and 12th gestation day during placenta formation. DNA microarrays were carried out on uterus from implantation and interimplantation samples obtained on day 8. The results allowed us to select genes potentially involved in embryo death; these were individually confirmed by RT-qPCR, and their expressions were also followed throughout pregnancy. We found that changes in expression of Calb1, Ttr, Expi, Inmt, Spink3, Rpgrip1, Krt15, Gzmc, Gzmb, Tdo2, and Afp were important for pregnancy success, since a different regulation in Cbs-KO mice was found. Also, differences in relationships among selected genes were observed, indicating a dysregulation of these genes in Cbs-KO females. In conclusion, our data provide more information on the gene expression cascade and its timely regulated process required for a successful pregnancy. In addition, we unveil new potential avenues to explore further investigations in pregnancy loss.reproduction; hyperhomocysteinemia; uterus IN EPIDEMIOLOGICAL AND META-ANALYSIS studies, hyperhomocysteinemia (Hhcy) has been found to be a risk factor for placentally mediated diseases, such as preeclampsia, spontaneous abortion, and placental abruption (50). In case-control studies, it has been also reported that homocysteine (Hcy) levels are frequently elevated in complicated pregnancies due to preeclampsia or umbilical placental vascular disease over those present in the normal pregnancy group (11,37,54).Hcy is a nonprotein sulfur amino acid and a substrate for cystathionine -synthase (Cbs) in the transsulfuration pathway, which represents its main metabolic fate. Alternatively, Hcy can be converted into methionine through the remethylation pathway. Three metabolic reactions using different methyl donors are known; one uses betaine, and the reaction is catalyzed by betaine-homocysteine methyltransferase, the second one catalyzed by 5-methyltetrahydrofolate-homocysteine methyltransferase uses as donor 5-methyltetrahydrofolate (43), and the third one is catalyzed by S-methylmethionine-homocysteine methyltransferase with methyl donor S-methylmethionine (46). These metabolic pathways are expressed in different tissues during development. Thus, Cbs is expressed in liver, pregnant myometrium, and decidual tissue, whereas methionine synthase is expressed in all embryonic tissues, the liver being the primary site of activity for these enzymes (48,51,58).Cbs-deficient [Cbs knockout...